42 Scientific and technological services, namely quality control of the metabolic measurement, univariate and multivariate statistical analysis for feature extraction, discovery of metabolic biomarkers, training of supervised machine learning models on metabolic data, annotation of spectral features with chemical structures, stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication; industrial analysis and research services in the field of biotechnology, namely, discovery of biomarker and stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication; research and development services, in relation to biotechnology, pharmacology, metabolomics; genetic engineering services; research and development in the field of medical diagnostics; design, development, programming and implementation of software and computerized databases; computerised scientific research, testing and analysis; design and development of computer hardware; software as a service featuring software for quality control of the metabolic measurement, univariate and multivariate statistical analysis for feature extraction, discovery of metabolic biomarkers, training of supervised machine learning models on metabolic data, annotation of spectral features with chemical structures, stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication; rental of computer software for data processing; software as a service (SaaS) featuring software for quality control of the metabolic measurement, univariate and multivariate statistical analysis for feature extraction, discovery of metabolic biomarkers, training of supervised machine learning models on metabolic data, annotation of spectral features with chemical structures, stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication in the field of metabolome; provision of information, in relation to pharmacology, metabolomics